Skip to main content
AmigoFish

Episode 209: Blast Crisis

From Core EM - Emergency Medicine Podcast ·

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

https://coreem.net/podcast/episode-209-blast-crisis/

We dive into the recognition and management of blast crisis.

Hosts:

Sadakat Chowdhury, MD

Brian Gilberti, MD

https://media.blubrry.com/coreem/content.blubrry.com/coreem/Blast_Crisis.mp3

Download (https://media.blubrry.com/coreem/content.blubrry.com/coreem/Blast_Crisis.mp3)

2 Comments (https://coreem.net/podcast/episode-209-blast-crisis/#comments)

Tags: Hematology (https://coreem.net/tag/hematology/), Oncology (https://coreem.net/tag/oncology/)

Show Notes

Topic Overview

- Blast crisis is an oncologic emergency, most commonly seen in chronic myeloid leukemia (CML).

- Defined by:

- >20% blasts in peripheral blood or bone marrow.

- May include extramedullary blast proliferation.

- Without treatment, median survival is only 3–6 months.

Pathophysiology & Associated Conditions

- Usually occurs in CML, but also in:

- Myeloproliferative neoplasms (MPNs)

- Myelodysplastic syndromes (MDS)

- Transition from chronic to blast phase often reflects disease progression or treatment resistance.

Risk Factors

- 10% of CML patients progress to blast crisis.

- Risk increased in:

- Patients refractory to tyrosine kinase inhibitors (e.g., imatinib).

- Those with Philadelphia chromosome abnormalities.

- WBC >100,000, which increases risk for leukostasis.

Clinical Presentation

- Symptoms often stem from pancytopenia and leukostasis:

- Anemia: fatigue, malaise.

- Functional neutropenia: high WBC count, but increased infection/sepsis risk.

- Thrombocytopenia: bleeding, bruising.

- Leukostasis/hyperviscosity effects by system:

- Neurologic: confusion, visual changes, stroke-like symptoms.

- Cardiopulmonary: ARDS, myocardial injury.

- Others: priapism, limb ischemia, bowel infarction.

- Rapid deterioration is common — early recognition is critical.

Diagnostic Workup

- CBC with differential: assess blast % and cytopenias.

- Peripheral smear and manual diff: confirm immature blasts.

- CMP: screen for tumor lysis syndrome:

- Elevated potassium, phosphate, uric acid.

- Low calcium.

- LDH & uric acid: markers of high cell turnover.

- Coagulation studies (PT, PTT): assess for DIC.

- Definitive tests (done inpatient): bone marrow biopsy, flow cytometry.

Emergency Department Management

- Resuscitation & ABCs: oxygen, IV fluids, vitals monitoring.

- Avoid aggressive transfusions:

- Risk of hyperviscosity with PRBCs and platelets.

- Initiate broad-spectrum antibiotics early:

- High suspicion for sepsis in functionally neutropenic patients.

- Consider antifungals for prolonged febrile neutropenia.

- Cytoreduction strategies:

- Hydroxyurea to lower WBCs quickly.

- Tyrosine kinase inhibitors (TKIs).

- High-dose chemotherapy.

- Early consultation with hematology/oncology is essential.

- Mutation testing may guide targeted therapy.

Prognosis

- Without treatment: median survival ~3 months.

- With treatment:

- Potential survival >1 year.

- Best outcomes in patients who enter a second chronic phase and undergo allogeneic stem cell transplant.

Ethical & Logistical Considerations

- Treatment may involve aggressive interventions with serious side effects.

- Important to assess:

- Patient goals of care.

- Capacity for informed consent.

- Resource limitations:

- Not all hospitals have oncology services.

- Patients may require transfer over long distances.

- Emphasize early, transparent discussions with patients and families.

Top 3 Take-Home Points

- Recognize early: Look for cytopenias, leukostasis, and rapid clinical decline.

- Resuscitate appropriately: Start antibiotics; be cautious with transfusions.

- Call for help: Early hematology/oncology involvement is essential for definitive care.

Read More (https://coreem.net/podcast/episode-209-blast-crisis/)

Back to Core EM - Emergency Medicine Podcast · Report a problem